CCTA (Cancer Treatment Centers of America) is an organization that’s currently working with both AllScripts and NantHealth. They’re all working as a team to create customized technical paths that empower Eviti to make use of high-quality clinical workflows. Eviti is a clinical decision sector that’s a part of NantHealth. “Clinical Pathways” is the name of a program that provides people with a comprehensive education regarding the treatment of cancer and how it works. It does this but at the same time doesn’t interfere with doctors and their workflows in any way. Clinical Pathways showcases any and all available and suitable treatment choices. People appreciate it because it often does away with uncertainty during the treatment process.
Cancer Treatment Centers of America is a group that’s based in many locations all across the United States. It has centers in cities such as Newnan, Georgia, Tulsa, Oklahoma, Goodyear, Arizona, Zion, Illinois, Philadelphia, Pennsylvania and, finally, Schaumburg, Illinois. Its main office, however, is in the sunny city of Boca Raton in Florida.
Cancer Treatment Centers of America consists of a total of five hospitals. These hospitals cater to patients who need in-depth cancer treatment all around the nation. Integrative cancer treatment is the primary focal point for the team at Cancer Treatment Centers of America. Integrative procedures are a big priority for the group. The organization also makes use of standard cancer treatment options. It employs standard treatment paths to take care of cancers in and of themselves. Examples of these treatments include immunotherapy, chemotherapy, surgery and radiation. Its integrative procedures are beneficial for the reduction of cancer side effects. Potential side effects of cancer include nervousness, depression, malnutrition, lymphedema, exhaustion, nausea and intense pain. Cancer Treatment Centers of America has been hard at work since launching back in 1988. Richard J. Stephenson created the group.
For more information follow CTCA on Twitter.